학술논문

Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: Long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial
Document Type
Article
Source
In: Leukemia and Lymphoma. (Leukemia and Lymphoma, 1 January 2015, 56(1):57-64)
Subject
Language
English
ISSN
10292403
10428194